Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
When Dana-Farber’s Catherine Wu, MD, was a newly minted physician in the mid-90s, there was just one major form of immunotherapy for cancer.
Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.
A worldwide coalition of researchers and clinicians find it is the most effective method for those with head and neck cancer.
“I was able to give someone a second chance on life in exchange for being sore for a couple of days. That made it easy for me to say yes,”
‘To have your life-threatening cancer cured, and then to die of not being able to breathe? It’s devastating.’
The technique prevents transplant rejection in the lab, a major advance for stem cell therapies.
Ten HIV-positive cancer patients to receive donated cord blood with rare resistance gene.
ASH 2018 conference highlights precision medicine, machine learning and gut microbiome.
Mouse study shows how transplanting patients’ own healthy blood stem cells can curb cancer, opening door to better treatments.
A new study analyzes nuances in a cohort of six people who also received stem cell transplants for blood cancers.
The haploidentical transplant process has vastly expanded the pool of bone marrow or stem cell donors.
Edwin Alyea, MD, and Don Lewis, who received a stem cell transplant in 2014 to treat his acute myeloid leukemia, explain the procedure.
Keith Rohleder participated in a clinical trial—which included chemotherapy and radiation—and then received a stem cell transplant.
Researchers are making headway against one of its deadliest side effects of bone marrow transplants.
The drug is approved to cut the risk of CMV reactivation following a stem cell transplant.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.